CALCIFIED LESIONS AND BEYOND

Sunday, February 26, 2023

11:15 AM – 12:30 PM ET

Moderator(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)
Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Rani K. Hasan, MD MHS

Assistant Professor of Medicine
Johns Hopkins University , Maryland, United States

Disclosure(s): No financial relationships to disclose
John P. Reilly, MD

Chief of Cardiology
Stony Brook Southampton Hospital
Stony Brook, New York, United States

No relationships to disclose

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

Rani K. Hasan, MD MHS: No financial relationships to disclose